Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Open or Minimally Invasive Surgeries Equal for Esophageal Cancer

By HospiMedica International staff writers
Posted on 06 Sep 2012
Minimally invasive esophagectomy (MIE) matched open surgery for survival in patients with esophageal cancer and led to examination of significantly more lymph nodes, according to a new study.


Researchers at the University of Sydney (Australia) conducted a systematic review of the literature using MEDLINE, PubMed, EMBASE, and the Cochrane databases (1950-2012). More...
The researchers then compared all eligible published studies with adequate oncologic data comparing MIE with open resection for carcinoma of the esophagus or esophagogastric junction. The analysis includes the extent of lymph node (LN) clearance, number of LNs retrieved, staging, geographic variance, and mortality. In all, 16 case-control studies with 1,212 patients undergoing esophagectomy were included.

The results showed that the median number of LNs found in the MIE and open groups were 16 and 10, respectively, with a significant difference favoring MIE. In comparing LN retrieval in Eastern versus Western studies, the researchers found a significant difference in Western centers favoring MIE. No statistical significance in pathologic staging was found between the open and MIE groups. Generally, no statistically significant difference was found between the open and MIE groups for survival within each time interval (30 days and 1, 2, 3, and 5 years), although the difference favored the MIE group. The study was published in the August 2012 issue of Archives of Surgery.

“The evidence suggests the use of minimally invasive esophagectomy is no better or worse in achieving similar oncologic outcomes than are open techniques,” concluded lead author Guy Eslick, PhD, and colleagues. “Further randomized controlled studies are needed to provide credible clinical evidence of the oncologic outcomes of open techniques versus minimally invasive esophagectomy.”

Esophagectomy is the surgical removal of all or part of the esophagus. There are two main types of esophagectomy; a trans-hiatal esophagectomy (THE) is performed on the neck and abdomen simultaneously; a trans-thoracic esophagectomy (TTE) involves opening the thorax. In most cases, the stomach is transplanted into the neck and the stomach takes the place originally occupied by the esophagus. In some cases, the removed esophagus is replaced by another hollow structure, such as the patient's colon.

Related Links:

University of Sydney



Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Head Rest
Medifa 61114_3
Mammo DR Retrofit Solution
DR Retrofit Mammography
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.